TP53BP1 and prostate carcinoma: In prostate cancer cells with DTX3L overexpression, the negative regulatory effect of TIRR on 53BP1 is impaired, which induces HR deficiency and chromosomal instability and results in high sensitivity to poly (ADP-ribose) polymerase (PARP) inhibitors.